• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测肝细胞癌患者经动脉化疗栓塞不完全反应的磁共振成像特征:一项符合STROBE标准的研究。

Magnetic resonance imaging features predictive of an incomplete response to transarterial chemoembolization in patients with hepatocellular carcinoma: A STROBE-compliant study.

作者信息

Kim Yeun Jeong, Lee Min Hee, Choi Seo Youn, Yi Boem Ha, Lee Hae Kyung

机构信息

Department of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Gyeonggi-do, Korea.

出版信息

Medicine (Baltimore). 2019 May;98(19):e15592. doi: 10.1097/MD.0000000000015592.

DOI:10.1097/MD.0000000000015592
PMID:31083245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6531079/
Abstract

To identify pretreatment magnetic resonance imaging (MRI) features associated with an incomplete response (IR) to transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).The medical records of 89 patients with HCC who had undergone a first TACE were reviewed retrospectively. The size, visual attenuation in the arterial phase, signal intensity (SI) on T1-, T2-, and diffusion-weighted images, and apparent diffusion coefficient (ADC) values of each lesion were evaluated on pretreatment images. The response to TACE was routinely assessed at 4 weeks post-treatment by 4-phase computed tomography. The HCC patients were classified as complete or incomplete responders based on the arterial-phase enhancement of the target lesion.In multivariate analysis, larger lesion diameter (P = .004, OR = 1.06 per millimeter, 95% CI = 1.02-1.11), faint enhancement on arterial phase (P = .021, OR = 3.24, 95% CI = 1.22-9.14), and non-low SI on T1-weighted images (P = .016, OR = 3.36, 95% CI = 1.29-9.32) were significantly associated with increased odds of an IR to TACE in HCC patients.An iso-to-high T1-weighted SI by pretreatment MRI was an independent predictor of an incomplete response to TACE in patients with HCC, in addition to faint arterial enhancement and lesion size.

摘要

识别肝细胞癌(HCC)患者经动脉化疗栓塞术(TACE)后不完全缓解(IR)相关的治疗前磁共振成像(MRI)特征。回顾性分析89例行首次TACE的HCC患者的病历。在治疗前图像上评估每个病灶的大小、动脉期视觉衰减、T1加权、T2加权和扩散加权图像上的信号强度(SI)以及表观扩散系数(ADC)值。治疗后4周通过四期计算机断层扫描常规评估对TACE的反应。根据靶病灶的动脉期强化情况将HCC患者分为完全缓解者或不完全缓解者。多因素分析显示,较大的病灶直径(P = 0.004,OR = 每毫米1.06,95%CI = 1.02 - 1.11)、动脉期强化微弱(P = 0.021,OR = 3.24,95%CI = 1.22 - 9.14)以及T1加权图像上非低信号强度(P = 0.016,OR = 3.36,95%CI = 1.29 - 9.32)与HCC患者TACE后IR几率增加显著相关。除了动脉期强化微弱和病灶大小外,治疗前MRI显示等至高T1加权信号强度是HCC患者TACE不完全缓解的独立预测因素。

相似文献

1
Magnetic resonance imaging features predictive of an incomplete response to transarterial chemoembolization in patients with hepatocellular carcinoma: A STROBE-compliant study.预测肝细胞癌患者经动脉化疗栓塞不完全反应的磁共振成像特征:一项符合STROBE标准的研究。
Medicine (Baltimore). 2019 May;98(19):e15592. doi: 10.1097/MD.0000000000015592.
2
Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.C 臂 CT 在肝细胞癌经导管动脉化疗栓塞中的作用:与钆塞酸增强 MRI 比较的诊断性能和治疗反应预测价值。
AJR Am J Roentgenol. 2013 Sep;201(3):675-83. doi: 10.2214/AJR.12.10445.
3
Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation.经动脉化疗栓塞前后肝细胞癌的弥散加权成像:在生存预测和反应评估中的作用。
Abdom Radiol (NY). 2019 Aug;44(8):2740-2750. doi: 10.1007/s00261-019-02030-2.
4
[Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].[磁共振成像在经皮乙醇注射(PEI)或经动脉化疗栓塞(TACE)治疗肝癌随访中的作用]
Radiol Med. 1994 Dec;88(6):806-17.
5
Computed tomographic perfusion with 160-mm coverage: comparative analysis of hepatocellular carcinoma treated by two transarterial chemoembolization courses relative to magnetic resonance imaging findings.160 毫米覆盖范围的计算机断层灌注:两种经动脉化疗栓塞术治疗的肝细胞癌与磁共振成像结果的对比分析。
Abdom Radiol (NY). 2019 Jan;44(1):85-94. doi: 10.1007/s00261-018-1714-x.
6
Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?术中 C 臂双期锥形束 CT:能否用于预测肝细胞癌患者经载药微球 TACE 短期应答?
Radiology. 2013 Feb;266(2):636-48. doi: 10.1148/radiol.12112316. Epub 2012 Nov 9.
7
Transarterial Radioembolization Following Chemoembolization for Unresectable Hepatocellular Carcinoma: Response Based on Apparent Diffusion Coefficient Change is an Independent Predictor for Survival.不可切除肝细胞癌化疗栓塞后经动脉放射性栓塞:基于表观扩散系数变化的反应是生存的独立预测因素
Cardiovasc Intervent Radiol. 2018 Nov;41(11):1716-1726. doi: 10.1007/s00270-018-1991-3. Epub 2018 Jun 5.
8
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.经动脉化疗栓塞治疗肝细胞癌反应的影像学预测因素:放射病理学相关性研究。
Liver Transpl. 2012 Jun;18(6):727-36. doi: 10.1002/lt.23413.
9
Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.基于治疗前动态 CT 和纹理特征预测肝细胞癌经导管动脉化疗栓塞治疗反应。
AJR Am J Roentgenol. 2017 Oct;209(4):W211-W220. doi: 10.2214/AJR.16.17398. Epub 2017 Aug 16.
10
Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.不可切除肝细胞癌:经动脉化疗栓塞术后早期血管及细胞的系列变化——磁共振成像检测结果
Radiology. 2009 Feb;250(2):466-73. doi: 10.1148/radiol.2502072222.

引用本文的文献

1
Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.基于增强 MRI 的肿瘤内和肿瘤周围放射组学分析用于术前预测肝细胞癌经动脉化疗栓塞治疗反应。
BMC Cancer. 2023 Oct 24;23(1):1026. doi: 10.1186/s12885-023-11491-0.
2
The Role of Immediate Post-Procedural Cone-Beam Computed Tomography (CBCT) in Predicting the Early Radiologic Response of Hepatocellular Carcinoma (HCC) Nodules to Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE).术后即刻锥形束计算机断层扫描(CBCT)在预测肝细胞癌(HCC)结节对载药微球经动脉化疗栓塞术(DEB-TACE)的早期放射学反应中的作用
J Clin Med. 2022 Nov 29;11(23):7089. doi: 10.3390/jcm11237089.
3
Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC.钆塞酸二钠增强MRI的影像组学分析预测肝癌患者经动脉栓塞治疗的反应
Diagnostics (Basel). 2022 May 24;12(6):1308. doi: 10.3390/diagnostics12061308.
4
Liver MRI and clinical findings to predict response after drug eluting bead transarterial chemoembolization in hepatocellular carcinoma.肝脏 MRI 和临床发现预测肝癌经载药微球动脉化疗栓塞治疗后的反应。
Sci Rep. 2021 Dec 15;11(1):24076. doi: 10.1038/s41598-021-01839-6.
5
Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma.基于对比增强磁共振成像的放射组学分析预测肝细胞癌经动脉化疗栓塞术的治疗反应
Front Oncol. 2021 Mar 31;11:582788. doi: 10.3389/fonc.2021.582788. eCollection 2021.

本文引用的文献

1
MRI features of hepatocellular carcinoma related to biologic behavior.肝细胞癌与生物学行为相关的磁共振成像特征
Korean J Radiol. 2015 May-Jun;16(3):449-64. doi: 10.3348/kjr.2015.16.3.449. Epub 2015 May 13.
2
2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm.2014年韩国肝癌研究组-国立癌症中心肝细胞癌管理实践指南:肝癌诊断算法
Dig Dis. 2014;32(6):764-77. doi: 10.1159/000368020. Epub 2014 Oct 29.
3
Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome.肝癌的化疗栓塞治疗:1 个月时的表观扩散系数反应是结局的独立预测因子。
Radiology. 2014 Mar;270(3):747-57. doi: 10.1148/radiol.13130591. Epub 2013 Dec 12.
4
Characterization of 1-to 2-cm liver nodules detected on hcc surveillance ultrasound according to the criteria of the American Association for the Study of Liver Disease: is quadriphasic CT necessary?根据美国肝病研究协会的标准对 HCC 监测超声检查中发现的 1 至 2cm 肝结节进行特征描述:是否需要进行四期 CT 检查?
AJR Am J Roentgenol. 2013 Aug;201(2):314-21. doi: 10.2214/AJR.12.9341.
5
Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.经动脉化疗栓塞术治疗不可切除肝细胞癌患者的放射学反应预测生存。
Aliment Pharmacol Ther. 2012 Jun;35(11):1343-50. doi: 10.1111/j.1365-2036.2012.05089.x. Epub 2012 Apr 8.
6
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.经动脉化疗栓塞治疗肝细胞癌反应的影像学预测因素:放射病理学相关性研究。
Liver Transpl. 2012 Jun;18(6):727-36. doi: 10.1002/lt.23413.
7
Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.计算机断层扫描和磁共振成像诊断小肝细胞癌和发育不良结节的准确性和分歧:活检的作用。
Hepatology. 2012 Mar;55(3):800-6. doi: 10.1002/hep.24746. Epub 2012 Jan 30.
8
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.日本肝细胞癌的管理:日本肝脏学会(JSH)2010 年更新版提出的基于共识的临床实践指南。
Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9.
9
Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.肝癌的化疗栓塞:362 例患者队列中肿瘤反应和生存的多因素分析预测因素。
J Vasc Interv Radiol. 2011 Jul;22(7):917-23. doi: 10.1016/j.jvir.2011.03.005. Epub 2011 May 14.
10
Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.分析钆贝葡胺增强 MRI 检查在高危 HCC 患者中对 1-2cm 肝脏小结节的特征表现。
Radiology. 2011 Jun;259(3):730-8. doi: 10.1148/radiol.11101549. Epub 2011 Mar 1.